Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks Asta , that’s very true.
Currently there are about 7m shares available to borrow
and it’s been around that level for a good while.
Paragraph 1 = All true
Paragraoh 2 = SNO will have zero relevance, come and go like it never happened
The antidote for low prices is...
...low prices
Warrant conversions taking some cash off the table
no more no less ..
RSI now under 35 someone`s gonna buy ...
RSI is at 37 , last time we were here we rallied from 1.13 to 1.47 in 4 sessions .
Thanks Lykri, I wonder if anyone here willing to call MHRA to see what
they can read into how developed our application is .
I have spoken to them three times , they are helpful but I`ve left
every call with more questions than answers ...
The number is ( from outside UK )
0044 203 080 6000
....then its options 3 , then 2 then 1 ...
You can hit the options as soon as the message starts ...
Lykri - do you think HTA is part of the GMP application process or separate, even though I saw Flipper post that the inspections can be somewhat in tandem .. ??
Soj , whitewater is right….
We do not accept your resignation !
Sorry to see you go Soj
Check your PM
Well I live in London which the last time I looked out of my window
was still in England which happens to be in the U.K.
There is no rationing of anything , about 3 weeks ago there was a
minor distribution concern that of course got reported in the news and
of course caused panic buying.
There is no hold up of any sort here and I assure you any delay is down
to Advent.
Flip - I spoke to MHRA again today
… didn’t get much but I’m sure the certification
is not related to anything else and it’s as simple as
Inspection , corrections list , follow up inspection and then hopefully
Certification ….
Understood , I thought it was a technical thing.
I spoke to MHRA again today …. Nothing concrete to report from me on that
I’m afraid
Can you copy over the link please Lykri...
HTA site says last update 21st Sep 21 ...
Kind of need an 19 close ... possible ..
Well in that case , re the science , you will have forgotten more than I know but if you`ve got `a` patient 12 years alive , considering SoC is 3% at 5 years , then I cant see as a scientist you could be sure to attribute that to NVCR... I would imagine there's a pretty good chance that SoC has some 10year + survivors ...
Sooooo...transparent ... hahahah
Bigger would not need to go to Bethesda to discuss exercising warrants , he will have pre hedged (already sold) cash shares and simply replaced them with new shares issued against exercising his warrants.
Certainly explains the suppressed price ... some significant warrant holders have an in price of below zero so taking off some risk is understandable .
Flip , I know you know but the data was ready last late summer for release in September 2020 and I guarantee you the certification is `on the regulators desk ` , now whether there`s been a couple of to and fro's on that and its literally awaiting a stamp , no one knows but I know 100% that there`s been no hold up at the MHRA.
Iwasadiver ...
You see Howard has Non-H Lymph ... he says he`s going to work through chemo
... and knowing him I believe he probably will !
Well of course that would def be a positive, and I guess
chase away the spectre of Dendreon
NEJM & The Lancet
I am banking on the final hurdle to the journal article being published is the certification of Sawstone , something many of us check for everyday.
If the certification is the catalyst to the journal then it will be immediate, as :
You can google and see NEJM & The Lancet have published all manner of articles on literally everyday of the week, there is no more waiting to be fitted in .. or hold the front page
I can not find any trial even close to ours that has allowed a journal the exclusive on a 14 year PH3 TLD release, which means to me the deal would be publish when LP says publish ...
also that pathetic report was for all trials failed and passed , we have to consider ours has passed .. time for successful PHASE 3 trials DL to TLD I`d go all under 9 months and I bet its actually < 6 months
Flipper, you should call them I have 3 times ..
from the US : + 44 203 080 6000
then option 3 then option 2 then option 1 .
...they are very helpful .
Utter rubbish, you are quoting some pathetic report that spoke about data lock to journal publication date and even then the time period of that study obviously did not take in to account that 100% of data these days is collated digitally . LP had the data ready to go in AUGUST 2020 as per her `data next month` ( sep 2020) quote ..
..no it cant ...
you can look at the patterns / amounts , times etc but you can only make an educated guess ..
Some times its 100% obvious sometimes not so ...
Flip , whilst I’m the first to question everything they say ,
I do believe them when they say it’s all about the journal and whilst there may well be
Conferences that follow , they’re not gonna alert anyone via an LBA.
Flip ‘ no financing till after Data ‘
Definitive market influencing forward looking statement
in the last 10q.
I bought a significant amount of shares because of that statement.
Good post Flip , all very plausible
Snap - I`ve also used Mayer Brown for years , a very good company
Why on earth have you posted that amateur hour rubbish..